Cardiology, Critical Care Medicine, Emergency Medical ServiceTIMECARDIINCT06218329
TIMECARD(TaIwan Network of Post-arrest ManagEment for CARDiac Arrest)IIRegistry
An observational study of Cardiology, Critical Care Medicine, Emergency Medical Service, run by National Taiwan University Clinical Trial Center at 1 site in Taiwan.
Trial summary
This study aims to collect the post-cardiac arrest patients with ICU admission. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cardiology, Critical Care Medicine, Emergency Medical Service
- How many people
- 1,000 participants
- Where
- 1 siteTaiwan
- Study dates
- 1 Jan 2022to 31 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: This study will enroll patients with who arrived at the emergency department with non-traumatic and admitted to the ICU.
Who may be able to join
- non-traumatic cardiac arrest patients
- Admitted to the ICU
Who cannot join
- Below 18 year old
- Pregnant
- Terminal illness or not receiving medical treatment
- When emergency ICU crowded can not provide Critical Care
Trial locations and contacts
1 site in 1 country.
Taiwan1 site, 1 recruiting
- Recruiting
Department of Emergency Medicine, National Taiwan University Hospital
Taipei, 100
Chien-Hua Huang, 2312-3456 ext. 262831, chhuang5940@ntu.edu.tw
About this study
Official title: TIMECARD (TaIwan Network of Post-arrest ManagEment for CARDiac Arrest) II Registry
This study aims to collect the post-cardiac arrest patients with ICU admission.
Read the detailed description
The purpose of this study is to establish protocolized and standard post-arrest care as well as constitute a multicenter registry of post-arrest survivors, and thus to develop the Taiwan predictive model of cardiac arrest survivors. The registry system may help evaluate the severity of disease illness and improve the post-arrest care.
- Keywords
- Prognosis, post-cardiac arrest syndrome, Sudden Cardiac Arrest, registry database, predictive model
- Medical subject headings
- Post-Cardiac Arrest Syndrome, Death, Sudden, Cardiac
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of cases
Measured: 2024/12/31
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jan 2024
- Study start1 Jan 2022
- Primary completion31 Dec 2024 (estimated)
- Study completion31 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cardiology, Critical Care Medicine, Emergency Medical ServiceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Clinical Trial Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, National Taiwan University Clinical Trial Center, National Taiwan University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06218329
- Sponsor's protocol ID
- 202201091RINB
- Acronym
- TIMECARDII
- Status last verified
- Oct 2023
- First submitted
- 17 Oct 2023
- Last updated
- 23 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- TIMECARD (TaIwan Network of Post-arrest ManagEment for CARDiac Arrest) II Registry
- ClinicalTrials.gov ID
- NCT06218329
- Acronym / sponsor ID
- TIMECARDII / 202201091RINB
- Keywords
- Prognosis, post-cardiac arrest syndrome, Sudden Cardiac Arrest, registry database, predictive model
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- National Taiwan University Clinical Trial CenterUniversity, hospital or other
- Study start
- 1 Jan 2022 (actual)
- Primary completion
- 31 Dec 2024 (estimated)
- Study completion
- 31 Dec 2024 (estimated)
- First posted
- 23 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to collect the post-cardiac arrest patients with ICU admission.
Detailed description
The purpose of this study is to establish protocolized and standard post-arrest care as well as constitute a multicenter registry of post-arrest survivors, and thus to develop the Taiwan predictive model of cardiac arrest survivors. The registry system may help evaluate the severity of disease illness and improve the post-arrest care.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- This study will enroll patients with who arrived at the emergency department with non-traumatic and admitted to the ICU.
Key inclusion criteria (2 listed)
- non-traumatic cardiac arrest patients
- Admitted to the ICU
Key exclusion criteria (4 listed)
- Below 18 year old
- Pregnant
- Terminal illness or not receiving medical treatment
- When emergency ICU crowded can not provide Critical Care
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of cases
Time frame: 2024/12/31
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2024.
- Individual participant dataSharing planned: No
Related trials for Cardiology, Critical Care Medicine, Emergency Medical Service
Not yet recruitingPhase 1
The TTM and ASM Trial
Critical Care Medicine, Emergency Medical Services
RecruitingObservational study
Critical Hyperacute Assessment Research On Neurobiomarker Kinetics in Acute Brain Injury
Brain Injuries, Traumatic, Brain Injuries, Acute
Enrolling by invitationObservational study
A Study on the Impact of a New Canton-Wide First Responder System in Zug, Switzerland, on Survival After Adult Cardiac Arrest-Examining Early Life-Saving Organized Help, Fast Defibrillation, and Improved Outcomes for Out of Hospital Cardiac Arrest
Cardiac Arrest (CA), Cardiac Arrest With Successful Resuscitation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiology, Critical Care Medicine, Emergency Medical Service, run by National Taiwan University Clinical Trial Center at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Chien-Hua Huang (2312-3456 ext. 262831, chhuang5940@ntu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of cases (time frame: 2024/12/31). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2024.